SB4 in the Era of Biosimilars: Clinical Data and Real-World Experience
A biosimilar is a biological medicinal product that is highly similar to an already authorized original biological medicinal product. The introduction of biosimilars may allow for a reduction in health care costs, due to discount pricing. Current clinical studies and real-world data suggest that the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PCO Convin S.A.
2019-01-01
|
| Series: | Mediterranean Journal of Rheumatology |
| Subjects: | |
| Online Access: | https://www.mjrheum.org/assets/files/792/file170_679.pdf |